Kelly C. Allison
University of Pennsylvania · Rehabilitation Medicine
Active 1997–2026
Academic metrics are sourced from OpenAlex and public funding records; values may differ from Google Scholar.
About
Kelly C. Allison, Ph.D., is a Professor of Psychiatry at the Hospital of the University of Pennsylvania and serves as the Director of the Center for Weight and Eating Disorders within the Department of Psychiatry at the Perelman School of Medicine at the University of Pennsylvania. Her research focuses on weight management, eating behaviors, and related psychological factors, with a particular emphasis on developing and evaluating behavioral and pharmacological interventions for weight loss and eating disorders. Dr. Allison's work includes studying the psychological predictors of weight loss success, the development of assessment tools for food addiction, and the application of telehealth programs to support weight management in specific populations such as breast cancer survivors.
Research topics
- Medicine
- Internal medicine
- Emergency medicine
- Optics
- Physics
- Earth science
- Virology
- Environmental science
- Geology
Selected publications
Prolonged, Controlled Daytime versus Delayed Eating Impacts Weight and Metabolism
Current Biology · 2020-11-30 · 94 citations
articleOpen access1st authorCorrespondingJAMA Network Open · 2021-11-16 · 57 citations
articleOpen accessThis cohort study examines trends in care for eating disorders and other behavioral health conditions before and during the COVID-19 pandemic among commercially insured individuals in the US.
Psychopathology, disordered eating, and impulsivity in patients seeking bariatric surgery
Surgery for Obesity and Related Diseases · 2020-11-10 · 48 citations
articleOpen accessSenior authorThe Lancet Diabetes & Endocrinology · 2023 · 38 citations
BACKGROUND: Empagliflozin has been proposed as a treatment for COVID-19 on the basis of its anti-inflammatory, metabolic, and haemodynamic effects. The RECOVERY trial aimed to assess its safety and efficacy in patients admitted to hospital with COVID-19. METHODS: In the randomised, controlled, open-label RECOVERY trial, several possible treatments are compared with usual care in patients hospitalised with COVID-19. In this analysis, we assess eligible and consenting adults who were randomly allo…
The Lancet Child & Adolescent Health · 2024 · 34 citations
BACKGROUND: Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 (PIMS-TS), also known as multisystem inflammatory syndrome in children (MIS-C) emerged in April, 2020. The paediatric comparisons within the RECOVERY trial aimed to assess the effect of intravenous immunoglobulin or corticosteroids compared with usual care on duration of hospital stay for children with PIMS-TS and to compare tocilizumab (anti-IL-6 receptor monoclonal antibody) or anakinra (anti-IL-1 re…
Recent grants
NIH · $440k · 2017
NIH · $3.0M · 2017–2024
Frequent coauthors
- 89 shared
David B. Sarwer
Temple University
- 47 shared
Albert J. Stunkard
- 37 shared
Sindhu K. Srinivas
University of Pennsylvania
- 36 shared
Masayuki Saito Advance
University of Pennsylvania
- 36 shared
Harvey J. Grill
University of Pennsylvania
- 36 shared
Marjorie C. Treadwell
University of Michigan–Ann Arbor
- 36 shared
Thien T. Tran
National Hospital
- 36 shared
Eric B. Hekler
University of California, San Diego
Labs
Center for Weight and Eating DisordersPI
Similar researchers at University of Pennsylvania
- Resume-aware match score
- Save to shortlist
- AI-drafted outreach
See your match with Kelly C. Allison
PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.
- Free to start
- No credit card
- 30-second signup